Wendy Pan Joins Goodwin As Partner In Hong Kong
31 July 2019
Global law firm Goodwin has announced that Wenseng “Wendy” Pan has joined its life sciences practice as a partner in its Hong Kong office. Pan regularly advises Chinese, US and multinational life sciences and technology companies, as well as venture and private equity firms in structuring and negotiating mergers and acquisitions, private and public investments, and complex IPbased transactions. She is active in the US-China life sciences community and is a recognized deal maker and opinion leader.
“China is well on its way to becoming the second-largest biotech market in the world next to the United States. In addition, the Hong Kong stock exchange has become an attractive market for many global biotech companies to consider for their public offerings, and Chinese investors are a significant capital source for biotech companies around the world,” said Mitchell Bloom, chair of Goodwin’s life sciences practice.
Pan earned a J.D. and a PhD in Chemistry from Columbia University, and an undergraduate degree from Fudan University. She is registered to practice in the State of New York and before the US Patent & Trademark Office, and is a registered foreign lawyer in Hong Kong.
Goodwin represents leading public and private life sciences companies across their entire life cycles, including financings, capital market transactions, mergers and acquisitions, collaborations and licensing, intellectual property and regulatory matters.
